AstraZeneca’s CEO, a French-born Australian running an Anglo-Swedish company, is betting $50 billion on a strategy of making the US its largest market — while also pouring $15 billion into China. Each ...

AstraZeneca CEO Pascal Soriot joins 'Mad Money' host Jim Cramer to talk manufacturing expansion, growth plans, next-gen therapies, and more. Got a confidential news tip? We want to hear from you. Sign ...

AstraZeneca disclosed that Chief Executive Officer Pascal Soriot received an allocation of 101,495 ordinary shares following the vesting of a long-term incentive award under the AstraZeneca ...

Whether in China or the United States, Pascal Soriot knows how to capture headlines. In Washington last year, the chief executive revealed that Britain’s biggest company AstraZeneca would be putting ...

AstraZeneca ( (GB:AZN)) has issued an update. AstraZeneca has reported that deferred share awards granted in March 2023 under its AstraZeneca Deferred Bonus Plan have vested for senior executives, ...

Add Yahoo as a preferred source to see more of our stories on Google. U.S. President Donald Trump speaks during an announcement about lowering U.S. drug prices next to Secretary of Commerce Howard ...

AstraZeneca is giving Pascal Soriot a pay raise as the longtime CEO weathered a year of “significant geopolitical uncertainty” to advance the British pharma toward an ambitious 2030 goal. For 2025, ...

Feb 10 (Reuters) - AstraZeneca forecast steady 2026 profit growth on Tuesday, betting on demand for its cancer drugs while it boosts its pipeline and invests in the U.S. and China to counter ...